{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T09:13:29Z","timestamp":1770974009080,"version":"3.50.1"},"reference-count":11,"publisher":"The Journal of Food and Drug Analysis (JFDA), Food and Drug Administration, Taiwan (TFDA)","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T00:00:00Z","timestamp":1468454400000},"content-version":"vor","delay-in-days":956,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jfda-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Food and Drug Analysis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jfda.2013.09.023","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T17:00:57Z","timestamp":1382634057000},"page":"S13-S15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S","title":["Medication-assisted therapy for opioid addiction"],"prefix":"10.38212","volume":"21","author":[{"given":"Betty","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Saxon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25385","reference":[{"key":"10.1016\/j.jfda.2013.09.023_bib1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/nn1105-1429","article-title":"The neuroscience of addiction","volume":"8","author":"Volkow","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jfda.2013.09.023_bib2","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.288.14.1775","article-title":"Improving primary care for patients with chronic illness","volume":"288","author":"Bodenheimer","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jfda.2013.09.023_bib3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1001\/archgenpsychiatry.2011.121","article-title":"Adjunctive counseling during brief and extended buprenorphine\u2013naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial","volume":"68","author":"Weiss","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jfda.2013.09.023_bib4","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jfda.2013.09.023_bib5","first-page":"8","article-title":"Electronic health records: essential tools in integrating substance abuse treatment with primary care","volume":"3","author":"Tai","year":"2012","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.jfda.2013.09.023_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/19371918.2013.758975","article-title":"Treatment for substance use disorder: opportunities and challenges under the Affordable Care Act","volume":"28","author":"Tai","year":"2013","journal-title":"Soc Work Public Health"},{"key":"10.1016\/j.jfda.2013.09.023_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1377\/hlthaff.28.1.75","article-title":"Evidence on the Chronic Care Model in the new millennium","volume":"28","author":"Coleman","year":"2009","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.jfda.2013.09.023_bib8","first-page":"2","article-title":"Chronic disease management: what will it take to improve care for chronic illness?","volume":"1","author":"Wagner","year":"1998","journal-title":"Eff Clin Pract"},{"key":"10.1016\/j.jfda.2013.09.023_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2147\/SAR.S39982","article-title":"Integrating substance abuse care with community diabetes care: implications for research and clinical practice","volume":"4","author":"Ghitza","year":"2013","journal-title":"Subst Abuse Rehabil"},{"key":"10.1016\/j.jfda.2013.09.023_bib10","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/npp.2013.99","article-title":"An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African Americans","volume":"38","author":"Crist","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jfda.2013.09.023_bib11","doi-asserted-by":"crossref","DOI":"10.1007\/BF03391707","article-title":"Can substance use disorders be managed using the chronic care model? Review and recommendations from a NIDA Consensus Group","author":"McLellan","year":"2013","journal-title":"Public Health Reviews"}],"container-title":["Journal of Food and Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949813000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949813000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1021949813000872?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:15:57Z","timestamp":1666635357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1021949813000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1021949813000872"],"URL":"https:\/\/doi.org\/10.1016\/j.jfda.2013.09.023","relation":{},"ISSN":["1021-9498"],"issn-type":[{"value":"1021-9498","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-assisted therapy for opioid addiction","name":"articletitle","label":"Article Title"},{"value":"Journal of Food and Drug Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfda.2013.09.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}